HIGHLIGHTS
- who: -methyladenosine et al. from the Morehouse School of Medicine, United States Medical University, China have published the research: Identi cation and veri cation of IGFBP3 and YTHDC1 as biomarkers associated with immune in ltration and mitophagy in hypertrophic cardiomyopathy, in the Journal: (JOURNAL)
- what: As the flowchart showed in Figure 1, this study aimed to explore the potential role of m6A methylation modification in the diagnosis and pathogenesis of HCM. Pathway enrichment analysis was conducted to explore the distinct biological features between groups. This study identified two m6A regulators as novel HCM biomarkers and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.